GENE ONLINE|News &
Opinion
Blog

Deals
Funding Precision Medicine
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
Funding CAR T-cell Therapy
Blackstone Chips in $250 Million to Aid Autolus’ CAR-T Therapy
2021-11-09
Deals Drug Discovery
HitGen Ink Deal with Cambridge Molecular to Create a Deep Learning-Driven Drug Discovery Platform
2021-11-08
Parthenon Therapeutics Launches with $65 Million Series A to Advance Immuno-Oncology Treatment
2021-11-07
Licensing Gene Writing
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
Deals Gene Editing
Moderna Enters Gene Editing Market with Metagenomi Collaboration
2021-11-03
Funding NK Cell Therapy
San Diego Startup Nabs $140 Million Following BeiGene, Kite Partnerships
2021-11-03
Licensing Respiratory Disease
AstraZeneca Trims Pipeline By Selling Two Respiratory Drugs to Covis Pharma
2021-11-02
M&A Cell Therapy
Takeda Snags UK-Based Cell Therapy Collaborator to Boost Immuno-Oncology Portfolio
2021-10-27
Funding Cell Therapy
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
Licensing CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
Funding Lipid Nanoparticle
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Funding Small Molecule Drug
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
China IPO
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Funding Neurological Disorder
Axial Therapeutics to Advance Pipeline for Neurological Diseases with $37.25 Million Series C Funding
2021-10-17
1 … 26 27 28 29 30 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top